Vaxil Bio Stock Five Year Return
| VXL Stock | CAD 0.01 0.00 0.00% |
Vaxil Bio fundamentals help investors to digest information that contributes to Vaxil Bio's financial success or failures. It also enables traders to predict the movement of Vaxil Stock. The fundamental analysis module provides a way to measure Vaxil Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxil Bio stock.
Vaxil | Five Year Return |
Vaxil Bio Company Five Year Return Analysis
Vaxil Bio's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Vaxil Five Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Vaxil Bio is extremely important. It helps to project a fair market value of Vaxil Stock properly, considering its historical fundamentals such as Five Year Return. Since Vaxil Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vaxil Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vaxil Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
Vaxil Return On Tangible Assets
Return On Tangible Assets |
|
According to the company disclosure, Vaxil Bio has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Vaxil Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaxil Bio's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vaxil Bio could also be used in its relative valuation, which is a method of valuing Vaxil Bio by comparing valuation metrics of similar companies.Vaxil Bio is currently under evaluation in five year return category among its peers.
Vaxil Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Vaxil Bio from analyzing Vaxil Bio's financial statements. These drivers represent accounts that assess Vaxil Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vaxil Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.1M | 30.5M | 10.2M | 2.7M | 2.5M | 3.5M | |
| Enterprise Value | 3.0M | 29.0M | 8.0M | 1.2M | 1.1M | 1.1M |
Vaxil Fundamentals
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.1 | ||||
| Current Valuation | 449.79 K | ||||
| Shares Outstanding | 136.98 M | ||||
| Shares Owned By Insiders | 8.16 % | ||||
| Shares Owned By Institutions | 0.01 % | ||||
| Number Of Shares Shorted | 3.73 K | ||||
| Price To Earning | (1.40) X | ||||
| Price To Book | 2.39 X | ||||
| EBITDA | (252) | ||||
| Net Income | (254 K) | ||||
| Cash And Equivalents | 307 K | ||||
| Total Debt | 85 K | ||||
| Debt To Equity | 11.20 % | ||||
| Current Ratio | 1.07 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (561 K) | ||||
| Short Ratio | 1.77 X | ||||
| Beta | -3.67 | ||||
| Market Capitalization | 1.37 M | ||||
| Total Asset | 976 K | ||||
| Retained Earnings | (19.36 M) | ||||
| Working Capital | 891 K | ||||
| Net Asset | 976 K |
About Vaxil Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxil Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxil Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxil Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxil Stock Analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.